Before today, searching Google for “coronavirus” and “bats” mostly delivered epidemiological research papers and some pretty grim looking soup. Now, however, there’s also this: Mindful that it’s April 1 we emailed BAT’s flacks (that’s £65bn British American Tobacco), who assured that it’s “100 per cent legitimate”. So fair enough, here’s the press release:BAT’s US bio-tech subsidiary, Kentucky BioProcessing (KBP), is developing a potential vaccine for COVID-19 and is now in pre-clinical testing. If testing goes well, BAT is hopeful that, with the right partners and support from government agencies, between 1 and 3 million doses of the vaccine could be manufactured per week, beginning in June.OK, let’s pause there. No vaccines for coronaviruses have been developed in the 70 or so years
FT Alphaville considers the following as important:
This could be interesting, too:
Bradford DeLong writes Blanchard: Reopening the Economy—Noted
Bradford DeLong writes Scalzi: Back Into Quarantine—Noted
John H. Cochrane writes Magical monetary theory full review
Before today, searching Google for “coronavirus” and “bats” mostly delivered epidemiological...